Eagle Pharmaceuticals (EGRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 69,522 | 97,659 | 99,741 | 108,717 | 105,229 |
| Receivables | 130,858 | 41,149 | 45,335 | 52,659 | 44,868 |
| Inventories | 24,818 | 21,908 | 9,315 | 8,294 | 6,862 |
| TOTAL | $240,166 | $172,606 | $171,694 | $175,504 | $163,986 |
| Non-Current Assets | |||||
| PPE Net | 1,627 | 1,636 | 1,775 | 1,967 | 2,270 |
| Intangibles | 49,683 | 50,414 | 50,542 | 51,248 | 51,954 |
| Other Non-Current Assets | 28,689 | 29,076 | 32,250 | 35,523 | 41,758 |
| TOTAL | $79,999 | $81,126 | $84,567 | $88,738 | $95,982 |
| Total Assets | $320,165 | $253,732 | $256,261 | $264,242 | $259,968 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 23,725 | 25,607 | 8,000 | 8,000 | 8,000 |
| Accounts payable and accrued liabilities | 14,509 | 16,431 | 12,717 | 11,136 | 12,559 |
| Accrued Expenses | 63,408 | 32,338 | 27,714 | 25,528 | 21,414 |
| TOTAL | $101,642 | $74,376 | $48,431 | $44,664 | $41,973 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 19,489 | 21,371 | 23,253 |
| Other Non-Current Liabilities | 2,563 | 2,903 | 3,048 | 3,360 | 3,664 |
| TOTAL | $2,563 | $2,903 | $22,537 | $24,731 | $26,917 |
| Total Liabilities | $104,205 | $77,279 | $70,968 | $69,395 | $68,890 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,699 | 12,697 | 12,914 | 13,097 | 13,109 |
| Common Shares | 17 | 17 | 17 | 17 | 17 |
| Retained earnings | 119,920 | 75,862 | 82,058 | 87,680 | 84,068 |
| Other shareholders' equity | 254 | -205 | -1,348 | -1,099 | -330 |
| TOTAL | $215,960 | $176,453 | $185,293 | $194,847 | $191,078 |
| Total Liabilities And Equity | $320,165 | $253,732 | $256,261 | $264,242 | $259,968 |